PH12016501245A1 - Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine - Google Patents

Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine

Info

Publication number
PH12016501245A1
PH12016501245A1 PH12016501245A PH12016501245A PH12016501245A1 PH 12016501245 A1 PH12016501245 A1 PH 12016501245A1 PH 12016501245 A PH12016501245 A PH 12016501245A PH 12016501245 A PH12016501245 A PH 12016501245A PH 12016501245 A1 PH12016501245 A1 PH 12016501245A1
Authority
PH
Philippines
Prior art keywords
phenylephrine
antihistamine
stable
maleate salt
pharmaceutical composition
Prior art date
Application number
PH12016501245A
Inventor
Relinda G Angeles
Joyce Bedelia B Santos
Kennie U Dee
Original Assignee
Relinda G Angeles
Joyce Bedelia B Santos
Kennie U Dee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Relinda G Angeles, Joyce Bedelia B Santos, Kennie U Dee filed Critical Relinda G Angeles
Priority to PH12016501245A priority Critical patent/PH12016501245A1/en
Publication of PH12016501245A1 publication Critical patent/PH12016501245A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An aqueous oral liquid composition containing phenylephrine and a maleate salt of antihistamine, wherein the composition is palatable and the phenylephrine chemically stable even when exposed to high temperature.
PH12016501245A 2014-03-12 2016-06-23 Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine PH12016501245A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH12016501245A PH12016501245A1 (en) 2014-03-12 2016-06-23 Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/PH2014/000008 WO2015137829A1 (en) 2014-03-12 2014-03-12 Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
PH12016501245A PH12016501245A1 (en) 2014-03-12 2016-06-23 Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine

Publications (1)

Publication Number Publication Date
PH12016501245A1 true PH12016501245A1 (en) 2016-08-15

Family

ID=54072145

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016501245A PH12016501245A1 (en) 2014-03-12 2016-06-23 Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine

Country Status (2)

Country Link
PH (1) PH12016501245A1 (en)
WO (1) WO2015137829A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020013973A1 (en) * 2018-07-09 2020-01-16 Bayer Healthcare Llc An aqueous-based composition containing xantan gum as inhibitor of microbial growth
CN112472677A (en) * 2020-11-12 2021-03-12 澳美制药厂有限公司 Renin-resistant preparation and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
US8323695B2 (en) * 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
MX2011006567A (en) * 2008-12-19 2011-08-03 Novartis Ag Phenylephrine formulations with improved stability.

Also Published As

Publication number Publication date
WO2015137829A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
PH12016501236A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
IL269444B (en) New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
UA115773C2 (en) POWER COMPOUNDS, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM (OPTIONS)
EP4349406A3 (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole for use as a medicament
EA201790785A1 (en) Derivatives of tetrahydroisoquinoline
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
MX2016005395A (en) Stable formulation of insulin glulisine.
MX2015016676A (en) Stable oral solutions for combined api.
WO2014153495A3 (en) Novel stat3 inhibitors
EA201792290A1 (en) TABLET CONTAINING RIBOCYCLIB
EA201500821A1 (en) Derivatives of 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purines, their use as pharmaceuticals and pharmaceutical compounds
EA201690036A1 (en) COMPOSITION WITH EXTENDED GRIPPING, CONTAINING CYTEHAMINE GRANULES AND METHODS FOR ITS PREPARATION AND APPLICATION
PH12018501709A1 (en) Naphthridinedione derivatives
EA201890828A1 (en) OPTIMIZED TABLET WITH HIGH DOSE OF ACTIVE COMPOUND, CONTAINING MESALAZIN
AR100365A1 (en) WATERPROOF COMPOSITION INCLUDING IBUPROFEN AND PARACETAMOL IN COMBINATION, PROCESS TO MANUFACTURE AND INJECTOR DEVICE FOR ADMINISTRATE
PH12016502544A1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EA201990093A1 (en) TWO COMPONENT COMPOSITION
DK3258920T3 (en) SOLID PHARMACEUTICAL DOSAGE FORM SUITABLE FOR USE AS DRINKING WATER MEDICINE
PH12016501245A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
EA201691924A1 (en) PHARMACEUTICAL COMPOSITIONS
MX2017007596A (en) Process for manufacturing phenylephrine resinate particles; phenylephrine resinate particles; and use of phenylephrine resinate particles in pharmaceutical formulations.
EA201891885A1 (en) CONTAINING PREGABALINE HIGH-PUMPABLE THREE-LAYER TABLET WITH SLOW-DELIVERY FOR ORAL RECEPTION
IN2014MU01179A (en)
TWD168947S (en) Bottle
IN2014MU01178A (en)